Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • illuminaGA
    Member
    • Dec 2012
    • 71

    #1

    De novo RNA-Seq Assembly using Trinity with variable length reads

    Dear All, i am working on a project that will do De novo RNA-Seq Assembly using Trinity. Totally have 16 samples from 2 projects.

    1. 8 sample, PE150, 30x, Hiseq 2500
    2. another 8 sample, PE300, 100x, Miseq

    I am wondering that if the Trinity can take the reads with variable length reads? and is there any technical and biological differences impact on the result if the data from a different condition, platform, and reads lengths?

    Can you please give me some pointers? Appreciate it.
  • gringer
    David Eccles (gringer)
    • May 2011
    • 845

    #2
    That should be fine. Inchworm does a kmer-based assembly, so as long as the reads are longer than the size of the kmers, it should be okay.

    However, it'd be a good idea to do adapter and end trimming on the reads, particularly for the longer 300bp sequences.

    You'll get a more informative transcriptome from combining reads that are from multiple samples, because it increases the chance that any transcript will have sufficient coverage for good assemblies.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:35 AM
    0 responses
    7 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...